Gallium arsenide
Gallium arsenide ist in Anhang II als verbotener Stoff für kosmetische Mittel aufgeführt, die in der EU in Verkehr gebracht werden.
Eintragsdetails
Chemische Bezeichnung
Gallium arsenide
Chemische / IUPAC-Bezeichnung
Gallium arsenide
Regulatorische Informationen
CMR
| Kategorie | Carcinogenic | Mutagenic | Reprotoxic |
|---|---|---|---|
| Cat. 1B | ✓ | — | ✓ |
Kerndaten
Chemische Identität und Eigenschaften

Gallium arsenide
Gallium Arsenide can cause cancer according to California Labor Code. — California Office of Environmental Health Hazard Assessment (OEHHA)
- IUPAC-Name
- gallanylidynearsane
- Summenformel
- AsGa
- Molekulargewicht
- 144.645 g/mol
- Exakte Masse
- 143.84717 Da
- Topologische polare Oberfläche
- 0,0 Ų
- Wasserstoffbrücken-Donoren
- 0
- Wasserstoffbrücken-Akzeptoren
- 0
- Kovalente Einheiten
- 1
- Definierte Stereozentren
- 0
Auch bekannt als
15 weitere gemeldete Namen
Belege aus weiteren wissenschaftlichen Datenbanken
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Color/Form: Cubic crystals, dark gray with metallic sheen Quelle: Hazardous Substances Data Bank (HSDB)
- Color/Form: Gray cubic crystals Quelle: Hazardous Substances Data Bank (HSDB)
- Density: 5.31 at 77 °F (NTP, 1992) - Denser than water; will sink Quelle: CAMEO Chemicals
- Density: 5.3176 @ 25 °C Quelle: Hazardous Substances Data Bank (HSDB)
- Density: Lattice constant 5.6-54 Angstroms; dielectric constant 11.1; intrinsic resistivity @ 300 deg K= 3.7X10+8 ohm-cm; electron lattice mobility @ 300 deg K= 10,000 square cm/volt-sec; intrinsic charge density @ 300 deg K= 1.4X10+6/cc; electron diffusion constant @ 300 deg K= 310 square cm/sec; hole diffusion constant= 11.5 square cm/sec Quelle: Hazardous Substances Data Bank (HSDB)
- Density: 5.31 Quelle: Occupational Safety and Health Administration (OSHA)
- Melting Point: 2260 °F (NTP, 1992) Quelle: CAMEO Chemicals
- Melting Point: 1238 °C Quelle: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Melting Point: 1238 °C Quelle: Hazardous Substances Data Bank (HSDB)
- Melting Point: 2260 °F Quelle: Occupational Safety and Health Administration (OSHA)
- Odor: Garlic odor when moistened Quelle: Hazardous Substances Data Bank (HSDB)
- Physical Description: Gallium arsenide is an insoluble, high-boiling solid which may react very slowly with water or water vapor to evolve toxic gases such as arsine. It is used as a high-performance material in the semiconductor industry. Quelle: CAMEO Chemicals
- Physical Description: Gray crystals or powder; [CAMEO] Quelle: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Physical Description: Dark gray crystals with a metallic greenish-blue sheen or gray powder. Quelle: Occupational Safety and Health Administration (OSHA)
- Solubility: less than 1 mg/mL at 68 °F (NTP, 1992) Quelle: CAMEO Chemicals
- Solubility: <1 mg/mg in DMSO, 95% ethanol, methanol, and acetone; soluble in hydrochloric acid Quelle: Hazardous Substances Data Bank (HSDB)
- Solubility: In water, <1 mg/ml @ 20 °C Quelle: Hazardous Substances Data Bank (HSDB)
- Substance: Gallium Arsenide Quelle: NTP Technical Reports
- NTP Technical Report: TR-492: Toxicology and Carcinogenesis Studies of Gallium Arsenide (CASRN 1303-00-0) in F344/N Rats and B6C3F1 Mice (Inhalation Studies) (2000 ) Quelle: NTP Technical Reports
- Peer Review Date: 05/21/99 Quelle: NTP Technical Reports
- Conclusion for Male Rat: No Evidence Quelle: NTP Technical Reports
- Conclusion for Female Rat: Clear Evidence Quelle: NTP Technical Reports
- Conclusion for Male Mice: No Evidence Quelle: NTP Technical Reports
- Conclusion for Female Mice: No Evidence Quelle: NTP Technical Reports
- Summary: Under the conditions of these 2-year inhalation studies, there was no evidence of carcinogenic activity of gallium arsenide in male F344/N rats exposed to 0.01, 0.1, or 1.0 mg/m3. There was clear evidence of carcinogenic activity in female F344/N rats based on increased incidences of benign and malignant neoplasms in the lung. Increased incidences of benign neoplasms of the adrenal medulla and increased incidences of mononuclear cell leukemia were also considered to be exposure related. There was no evidence of carcinogenic activity in male or female B6C3F1 mice exposed to 0.1, 0.5, or 1.0 mg/m3.; Exposure to gallium arsenide caused a spectrum of nonneoplastic lesions in the lung of rats and mice, the larynx of male rats and hyperplasia of the tracheobronchial lymph node in mice. Quelle: NTP Technical Reports
- Carcinogen Classification: 1, carcinogenic to humans. (L135) Quelle: Toxin and Toxin Target Database (T3DB)
- Exposure Routes: Oral (L2) ; inhalation (L2); dermal (L2) Quelle: Toxin and Toxin Target Database (T3DB)
- First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. IMMEDIATELY call a physician and be prepared to transport the victim to a hospital even if no symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Ap Quelle: CAMEO Chemicals
- Signal: Danger Quelle: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
- GHS Hazard Statements: H350: May cause cancer [Danger Carcinogenicity]; H360F: May damage fertility [Danger Reproductive toxicity]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] Quelle: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
- Precautionary Statement Codes: P203, P260, P264, P270, P280, P318, P319, P405, and P501 (click each P-code to see the statement) Quelle: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
- Note: This chemical does not meet GHS hazard criteria for 6.2% (7 of 112) of reports. Quelle: European Chemicals Agency (ECHA)
- Signal: Danger Quelle: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H350 (88.4%): May cause cancer [Danger Carcinogenicity]; H360 (50.9%): May damage fertility or the unborn child [Danger Reproductive toxicity]; H372 (88.4%): Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] Quelle: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P203, P260, P264, P270, P280, P318, P319, P405, and P501 (click each P-code to see the statement) Quelle: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 112 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 7 of 112 reports by companies.; There are 6 notifications provided by 105 of 112 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)
- Signal: Danger Quelle: NITE-CMC
- GHS Hazard Statements: H350: May cause cancer [Danger Carcinogenicity]; H360: May damage fertility or the unborn child [Danger Reproductive toxicity]; H370: Causes damage to organs [Danger Specific target organ toxicity, single exposure]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] Quelle: NITE-CMC
- Precautionary Statement Codes: P203, P260, P264, P270, P280, P308+P316, P318, P319, P321, P405, and P501 (click each P-code to see the statement) Quelle: NITE-CMC
- Signal: Danger Quelle: Hazardous Chemical Information System (HCIS), Safe Work Australia
- Health Effects: Arsenic poisoning can lead to death from multi-system organ failure, probably from necrotic cell death, not apoptosis. Arsenic is also a known carcinogen, esepcially in skin, liver, bladder and lung cancers. (T1, L20) Quelle: Toxin and Toxin Target Database (T3DB)
- Toxicity Summary: Arsenic and its metabolites disrupt ATP production through several mechanisms. At the level of the citric acid cycle, arsenic inhibits pyruvate dehydrogenase and by competing with phosphate it uncouples oxidative phosphorylation, thus inhibiting energy-linked reduction of NAD+, mitochondrial respiration, and ATP synthesis. Hydrogen peroxide production is also increased, which might form reactive oxygen species and oxidative stress. Arsenic's carginogenicity is influenced by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. The binding of other arsenic protein targets may also cause altered DNA repair enzyme activity, altered DNA methylation patterns and cell proliferation. (T1, A17) Quelle: Toxin and Toxin Target Database (T3DB)
- Sources/Uses: Used in semiconductor applications; [Merck Index #4347] Quelle: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Industrial Processes with risk of exposure: Semiconductor Manufacturing [Category: Industry] Quelle: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Uses: In semiconductor applications (transistors, solar cells, lasers) Quelle: Hazardous Substances Data Bank (HSDB)
- Uses: Semiconductor in light-emitting diodes for telephone dials; magnetoresistance devices; thermistors; microwave generation Quelle: Hazardous Substances Data Bank (HSDB)
- Uses: Infrared emitters; photoelectronic transmission of data by optical fibers Quelle: Hazardous Substances Data Bank (HSDB)
- Uses: Gallium arsenide is used as a semiconductor, as well as in solar cells, x-ray detection diodes, and laser diodes. (L354) Quelle: Toxin and Toxin Target Database (T3DB)
Zugeordnet durch: Existing checksum-valid CAS to unique PubChem CID match. Abgerufen: 2026-08-31. Quelleneintrag öffnen
Wissenschaftliche Klassifizierungen und Gefahrenannotationen liefern Kontext und ersetzen nicht die oben gezeigte marktspezifische regulatorische Entscheidung.
Weitere Quellenabdeckung und Trefferstatus
| Quelle | Ergebnis | Geprüft |
|---|---|---|
| NIH PubChem PUG-View | Exakter Treffer | 2026-08-31 |
Ein erfasster Nicht-Treffer ist ein nützlicher Beleg dafür, dass die Quelle geprüft wurde; er ist keine Behauptung, dass der Stoff anderswo nicht existiert.
Am 2026-09-02 von NIH PubChem durch prüfsummengültigen CAS-Abgleich abgerufen. Chemische Eigenschaften ersetzen nicht die regulatorische Entscheidung auf dieser Seite.
Verwandte Einträge zu Gallium arsenide
Für diesen Eintrag gibt es nur wenige direkte Treffer; daher werden auch nahe liegende Einträge aus Anhang II angezeigt.
Proquinazid (ISO); 6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one
N-Ethyl-2-pyrrolidone; 1-ethylpyrrolidin-2-one
Aclonifen (ISO); 2-chloro-6-nitro-3-phenoxyaniline
Perfluorooctanoic acid
2-Ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate
Ammonium pentadecafluorooctanoate
Dimethyltin dichloride
4-Vinylcyclohexene
Bifenthrin (ISO); (2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-…
Tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one
Was Anhang II für Gallium arsenide bedeutet
Gallium arsenide ist in Anhang II der EU-Kosmetikverordnung (EG) Nr. 1223/2009 als verbotener Stoff aufgeführt und darf nicht absichtlich zugesetzt werden. Artikel 17 regelt gesondert unbeabsichtigte geringe Mengen, die bei guter Herstellungspraxis technisch unvermeidbar und mit der Sicherheitsanforderung nach Artikel 3 vereinbar sind.
Rezepturentwickler müssen ihre Inhaltsstoffe und Rohstoffe prüfen, um sicherzustellen, dass keiner davon diesen Stoff enthält. Lieferanten sollten auf Anfrage eine Dokumentation vorlegen, die die Abwesenheit bestätigt.
Die Seite zeigt außerdem 12 verwandte Anhangseinträge mit überschneidenden Kennungen, Anhangslogik oder Namensmustern.
Compliance-Checkliste
- Prüfen Sie, dass dieser Stoff in allen Rohstoffen und fertigen Rezepturen nicht enthalten ist.
- Fordern Sie von Rohstofflieferanten eine Abwesenheitsbestätigung oder ein Analysenzertifikat an.
- Dokumentieren Sie das Prüfergebnis in der Produktinformationsdatei (PIF).
- Dieser Stoff hat eine CMR-Einstufung. Prüfen Sie die CMR-Tabelle oben und den aktuellen Status nach Anhang II/III, bevor Sie ihn verwenden.
Häufig gestellte Fragen
Quellenhinweis zu Anhang II, Eintrag Gallium arsenide
Diese Seite fasst einen Eintrag aus Anhang II für Gallium arsenide aus öffentlichen Materialien der Europäischen Kommission zu kosmetischen Mitteln zusammen und ergänzt, soweit verfügbar, verknüpfte Treffer aus dem Verzeichnis oder bei Kennungen.
Nutzen Sie diese Eintragsseite, um die Bedingungen aus Anhang II für Gallium arsenide zu prüfen; bestätigen Sie jede endgültige regulatorische Entscheidung jedoch anhand des aktuellen amtlichen Anhangswortlauts und der Quelldateien.
Werkzeuge und nächste Schritte
Rezeptur prüfen
Fügen Sie eine vollständige INCI-Liste ein, um Gallium arsenide und andere markierte EU-Anhangseinträge in einem Durchgang zu finden.
INCI-CheckerEinträge vergleichen
Gallium arsenide nebeneinander mit einem anderen Anhangseintrag vergleichen, um Unterschiede bei Beschränkungen, Konzentrationen und Anhangszuordnung zu prüfen.
VergleichenDen Anhang durchsuchen
Alle Einträge in Anhang II ansehen und die regulatorischen Bedingungen der Stoffe in diesem Anhang vergleichen.
Anhang II öffnen